The global tetracyclines industry size is set for substantial growth, projected to reach a market share of US$ 41.62 billion by 2032, up from US$ 32.82 billion in 2020. This growth, forecasted at a Compound Annual Growth Rate (CAGR) of 2%, is attributed to the supportive policies for the pharmaceutical business and accessible grants extended …